Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Reports outline vaccines study findings from University of Otago
June 11th, 2008
New investigation results, 'Immunostimulatory biodegradable implants containing the adjuvant Quil-A--Part I: Physicochemical characterisation,' are detailed in a study published in Journal of Drug Targeting. "Sustained-release vaccines offer the potential to reduce, or obviate, the need for repeated dosing of vaccines. In this study, we report the development and characterisation of sustained-release lipid implants that release immunogenic, self-assembling colloidal particles," researchers in Dunedin, New Zealand report. "Lipid implants consisting of cholesterol (CHOL), phosphatidylcholine (PC), the adjuvant Quil-A (QA) and the model antigen ovalbumin (OVA) were...
Source: Vaccine Weekly (2008-06-11)
|
